Back

WWOX contributes to DNA damage, but not somatic instability in Huntington s disease

Petrozziello, T.; McLean, Z. L.; Boudi, A.; Huntress, S. S.; Granucci, E. J.; Field, G. A.; Monsanto, R. Z. B.; Castillo Torres, A. L.; Roy, J. C. L.; Kesavan, M.; Wu, M.; Doherty, N.; Sapp, E.; Pouladi, M. A.; Kegel-Gleason, K. B.; DiFiglia, M.; Gusella, J. F.; Mouro Pinto, R.; Sadri-Vakili, G.

2026-06-26 neuroscience
10.64898/2026.06.24.734331 bioRxiv
Show abstract

Huntingtons disease (HD), caused by a CAG repeat expansion in the huntingtin (HTT) gene, is characterized by progressive neurodegeneration and accumulation of DNA damage with multiple disease-modifier genes involved in DNA repair pathways. Previous studies have implicated ataxia telangiectasia mutated (ATM) signaling in the regulation of genomic stability and DNA damage repair (DDR) pathways in HD. ATM has also been linked to the WW domain-containing oxidoreductase (WWOX), a protein involved in DNA repair and maintenance of genomic stability, through the E3 ubiquitin ligase ITCH. However, whether this signaling pathway contributes to HD pathogenesis remains unknown. Here, we investigated the role of ATM-ITCH-WWOX signaling in HD. Our results revealed no significant alterations in total ATM, phosphorylated ATM (pATM-S1981), or ITCH in HD post-mortem prefrontal cortex (PFC) compared to controls. Although treatment of human neuroblastoma SH-SY5Y cells with HD PFC lysates did not alter pATM-S1981 levels, it increased histone H2AX phosphorylation at S139 ({gamma}-H2AX), a marker of DNA double-strand breaks. This finding suggested the presence of persistent DNA damage signaling independent of canonical ATM activation. Conversely, WWOX levels were increased in both HD PFC and HD embryonic stem cell-derived cortical neurons. Additionally, treatment of SH-SY5Y cells with recombinant human WWOX protein or WWOX overexpression increased {gamma}-H2AX levels, supporting a role for WWOX in promoting DNA damage. To determine whether WWOX contributed to DNA damage in HD, SH-SY5Y cells were treated with HD PFC lysates that were depleted of WWOX. Immuno-depletion of WWOX reduced the ability of HD PFC lysates to increase {gamma}-H2AX, suggesting that WWOX contributes to DNA damage in HD. Finally, overexpression of WWOX in RPE1-AAVS1-CAG115 cells did not affect somatic CAG repeat instability, despite persistent increases in {gamma}-H2AX levels. Collectively, our findings identify WWOX as a contributor to DNA damage in HD, acting independently of the ATM pathway.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
148 papers in training set
Top 0.1%
19.3%
2
Acta Neuropathologica Communications
89 papers in training set
Top 0.1%
13.5%
3
PLOS ONE
5266 papers in training set
Top 23%
7.6%
4
Scientific Reports
3612 papers in training set
Top 21%
4.7%
5
Human Molecular Genetics
141 papers in training set
Top 0.9%
2.5%
6
Movement Disorders
71 papers in training set
Top 0.4%
2.5%
50% of probability mass above
7
Brain
168 papers in training set
Top 1%
2.5%
8
Journal of Biological Chemistry
690 papers in training set
Top 4%
2.5%
9
Acta Neuropathologica
58 papers in training set
Top 0.7%
2.2%
10
International Journal of Molecular Sciences
494 papers in training set
Top 7%
1.8%
11
eneuro
439 papers in training set
Top 4%
1.8%
12
Cell Death & Disease
21 papers in training set
Top 0.2%
1.6%
13
JCI Insight
277 papers in training set
Top 5%
1.4%
14
Brain Communications
166 papers in training set
Top 2%
1.4%
15
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 33%
1.2%
16
Molecular Therapy
81 papers in training set
Top 1%
1.2%
17
eLife
5828 papers in training set
Top 55%
1.2%
18
Cells
249 papers in training set
Top 5%
1.1%
19
Neurotherapeutics
14 papers in training set
Top 0.2%
1.1%
20
Frontiers in Cellular Neuroscience
91 papers in training set
Top 1%
1.1%
21
Frontiers in Molecular Neuroscience
47 papers in training set
Top 1.0%
1.0%
22
The Journal of Neuroscience
1025 papers in training set
Top 9%
0.9%
23
Cell Death & Disease
126 papers in training set
Top 3%
0.9%
24
Journal of Biomedical Science
17 papers in training set
Top 0.3%
0.9%
25
iScience
1154 papers in training set
Top 33%
0.9%
26
Nature Communications
5641 papers in training set
Top 58%
0.6%
27
Science Advances
1243 papers in training set
Top 32%
0.6%
28
npj Genomic Medicine
36 papers in training set
Top 0.9%
0.6%
29
Molecular Neurodegeneration
55 papers in training set
Top 2%
0.6%
30
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.5%